Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:949-955

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gamble, J. R.
Right arrow Articles by Vadas, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gamble, J. R.
Right arrow Articles by Vadas, M. A.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:949-955.)
© 1995 American Heart Association, Inc.


Articles

TGF-ß and Endothelial Cells Inhibit VCAM-1 Expression on Human Vascular Smooth Muscle Cells

Jennifer R. Gamble; Sandy Bradley; Leanne Noack; Mathew A. Vadas

From the Hanson Centre for Cancer Research, IMVS, Adelaide, South Australia.

Correspondence to Jennifer R. Gamble, Hanson Centre for Cancer Research, IMVS, PO Box 14 Rundle Mall, Adelaide, 5000, South Australia.

Abstract Vascular smooth muscle cells (VSMCs) are normally devoid of the adhesion protein vascular cell adhesion molecule–1 (VCAM-1), which has, however, been observed on human VSMCs in atheroma. We now show that cultured human saphenous vein VSMCs express small amounts of VCAM-1 and that the cytokine tumor necrosis factor–{alpha} (TNF-{alpha}) induces, in a time- and dose-dependent fashion, a significant increase in its expression. Interleukin (IL)-4, IL-1, and to a lesser extent interferon gamma have similar effects. TNF-{alpha}–stimulated human VSMCs demonstrate increased binding of T lymphocytes that is totally VCAM-1 mediated. The cytokine transforming growth factor–ß (TGF-ß) at 2.0 ng/mL inhibited basal VCAM-1 expression by 84±8% and the induction by TNF-{alpha} by between 56±16% and 77±15% depending on the dose of TNF. Furthermore, coculture on opposing sides of a polycarbonate filter of human VSMCs with human umbilical vein endothelial cells also inhibited the induction of VCAM-1 by 47±6%. As active TGF-ß is produced upon the coculture of VSMCs and endothelial cells, we suggest that the close physical proximity of these cells in vivo is responsible for the lack of expression of VCAM-1 on VSMCs and that the interruption of this contact in atheroma is an important pathogenic event. As VCAM-1 not only serves as an adhesion molecule but also as a costimulator of immune cells, its expression may be crucial in the propagation of vascular lesions.


Key Words: atherogenesis • T cell adhesion • tumor necrosis factor • interleukin-4




This article has been cited by other articles:


Home page
Innate ImmunityHome page
H. Loppnow, K. Werdan, and M. Buerke
Invited review: Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms
Innate Immunity, April 1, 2008; 14(2): 63 - 87.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
E. P. Moiseeva
Adhesion receptors of vascular smooth muscle cells and their functions
Cardiovasc Res, December 1, 2001; 52(3): 372 - 386.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Tedgui and Z. Mallat
Anti-Inflammatory Mechanisms in the Vascular Wall
Circ. Res., May 11, 2001; 88(9): 877 - 887.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Braun, P. Pietsch, K. Schror, G. Baumann, and S. B. Felix
Cellular adhesion molecules on vascular smooth muscle cells
Cardiovasc Res, February 1, 1999; 41(2): 395 - 401.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Braun, P. Pietsch, A. Zepp, K. Schror, G. Baumann, and S. B. Felix
Regulation of Tumor Necrosis Factor-{alpha} and Interleukin-1ß Induced Adhesion Molecule Expression in Human Vascular Smooth Muscle Cells by cAMP
Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2568 - 2575.
[Abstract] [Full Text]


Home page
HypertensionHome page
F. Cambien, S. Ricard, A. Troesch, C. Mallet, L. Generenaz, A. Evans, D. Arveiler, G. Luc, J.-B. Ruidavets, and O. Poirier
Polymorphisms of the Transforming Growth Factor-ß1 Gene in Relation to Myocardial Infarction and Blood Pressure: The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study
Hypertension, November 1, 1996; 28(5): 881 - 887.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. W. Feinberg, M. K. Jain, F. Werner, N. E. S. Sibinga, P. Wiesel, H. Wang, J. N. Topper, M. A. Perrella, and M.-E. Lee
Transforming Growth Factor-beta 1 Inhibits Cytokine-mediated Induction of Human Metalloelastase in Macrophages
J. Biol. Chem., August 11, 2000; 275(33): 25766 - 25773.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Z. Mallat, A. Gojova, C. Marchiol-Fournigault, B. Esposito, C. Kamate, R. Merval, D. Fradelizi, and A. Tedgui
Inhibition of Transforming Growth Factor-{beta} Signaling Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Mice
Circ. Res., November 9, 2001; 89(10): 930 - 934.
[Abstract] [Full Text] [PDF]